A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences
暂无分享,去创建一个
[1] M. Sabom. Recollections of Death: A Medical Investigation , 1981 .
[2] A. Matsuki,et al. Uneventful total intravenous anaesthesia with ketamine for schizophrenic surgical patients. , 1997, European journal of anaesthesiology.
[3] K. Jansen. Ketamine--can chronic use impair memory? , 1990, The International journal of the addictions.
[4] C. Morgan,et al. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. , 2000, Addiction.
[5] H. Emrich,et al. Psychotomimesis mediated by kappa opiate receptors , 1986, Science.
[6] Awareness during general anaesthesia--incidence, clinical relevance and monitoring. , 1997, Acta anaesthesiologica Scandinavica. Supplementum.
[7] W. Abruzzi. Drug-induced psychosis , 1980 .
[8] The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report. , 1998, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[9] R. Faull,et al. Immediate-early genes, kindling and long-term potentiation , 1989, Neuroscience & Biobehavioral Reviews.
[10] Ketamine abuse , 2016, Reactions Weekly.
[11] Carol A. Tamminga,et al. Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.
[12] M E Durieux,et al. Synergistic Inhibition of Muscarinic Signaling by Ketamine Stereoisomers and the Preservative Benzethonium Chloride , 1997, Anesthesiology.
[13] W. Carpenter. The schizophrenia ketamine challenge study debate , 1999, Biological Psychiatry.
[14] J. Olney,et al. NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.
[15] K. Jansen,et al. Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins. , 1990, Medical hypotheses.
[16] J. Olney,et al. Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity , 1996, Schizophrenia Research.
[17] Moussa Awuonda. Swedes alarmed at ketamine misuse , 1996, The Lancet.
[18] J. Bakalar,et al. Psychedelic Drugs Reconsidered , 1979 .
[19] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[20] Bita Moghaddam,et al. Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.
[21] K. Jansen. Non-medical use of ketamine. , 1993, BMJ.
[22] D. Rogo. Ketamine and the Near-Death Experience , 1984 .
[23] B. Tranmer,et al. Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia. , 1996, Molecular and chemical neuropathology.
[24] D. Corbett. Ketamine blocks the plasticity associated with prefrontal cortex self-stimulation , 1990, Pharmacology Biochemistry and Behavior.
[25] B. Moghaddam. Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[26] J. Gill,et al. Ketamine in non-hospital and hospital deaths in New York City. , 2000, Journal of forensic sciences.
[27] S. Rothrock,et al. Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. , 1998, Annals of emergency medicine.
[28] J. Smith,et al. Respiratory arrest following intramuscular ketamine injection in a 4-year-old child. , 1993, Annals of emergency medicine.
[29] J. Olney,et al. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. , 1989, Science.
[30] J. Clements,et al. Pharmacokinetics and analgesic effects of i.m. and oral ketamine. , 1982, British journal of anaesthesia.
[31] D G Lambert,et al. Ketamine: its mechanism(s) of action and unusual clinical uses. , 1996, British journal of anaesthesia.
[32] W. Adams,et al. The brain drain. , 1969, Journal of the Irish Medical Association.
[33] A. Thomson,et al. An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? , 1985, Nature.
[34] Donn W Ketcham. Where there is no Anaesthesiologist: The Many Uses of Ketamine , 1990, Tropical doctor.
[35] J. Olney,et al. Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist Neurotoxicity , 1998, Neuropsychopharmacology.
[36] F. Servin,et al. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. , 1996, British journal of anaesthesia.
[37] Nolan Miller,et al. The Scientist: A Novel Autobiography , 1978 .
[38] Anil K Malhotra,et al. Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.
[39] B. Hope. Cocaine and the AP‐1 Transcription Factor Complex , 1998, Annals of the New York Academy of Sciences.
[40] J. Coyle. The Nagging Question of the Function ofN-Acetylaspartylglutamate , 1997, Neurobiology of Disease.
[41] J. Mussini,et al. Is Ketamine or Its Preservative Responsible for Neurotoxicity in the Rabbit? , 1993, Anesthesiology.
[42] D. Choi,et al. Ketamine protects cultured neocortical neurons from hypoxic injury , 1986, Brain Research.
[43] D. Hunt. Pulse Check: National Trends in Drug Abuse. , 1997 .
[44] T. Gordh,et al. Histopathology after repeated intrathecal injections of preservative-free ketamine in the rabbit: a light and electron microscopic examination. , 1994, Anesthesia and analgesia.
[45] G. Hempelmann,et al. The effects of thiopentone, etomidate, ketamine and midazolam on several bactericidal functions of polymorphonuclear leucocytes in vitro. , 1995, European journal of anaesthesiology.
[46] A. Malhotra,et al. The Apolipoprotein E ε4 Allele Is Associated with Blunting of Ketamine-Induced Psychosis in Schizophrenia: A Preliminary Report , 1998, Neuropsychopharmacology.
[47] T. Honoré,et al. Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons. , 1987, European journal of pharmacology.
[48] K. L. Leenders,et al. Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET) , 1997, European Neuropsychopharmacology.
[49] V. Grover,et al. The effect of music on ketamine induced emergence phenomena , 1992, Anaesthesia.
[50] R. Beninger,et al. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid , 1997, Neuroscience.
[51] N. Lindefors,et al. Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex , 1997, Brain Research.
[52] M. Morgan,et al. Effects of Droperidol and Nitrazepam on Emergence Reactions Following Ketamine Anesthesia , 1973, Anesthesia and analgesia.
[53] S. Zielmann,et al. [The effects of long-term sedation on intestinal function]. , 1995, Der Anaesthesist.
[54] G. Plourde,et al. Ketamine increases the amplitude of the 40-Hz auditory steady-state response in humans. , 1997, British journal of anaesthesia.
[55] D. Gore,et al. Superiority of oral ketamine as an analgesic and sedative for wound care procedures in the pediatric patient with burns. , 1997, The Journal of burn care & rehabilitation.
[56] G. Pierini,et al. A fatal ketamine poisoning. , 1994, Journal of forensic sciences.
[57] L. Favalli,et al. Influence of different anaesthetics on extracellular aminoacids in rat brain , 2000, Journal of Neuroscience Methods.
[58] Olney Jw. NEUROTOXICITY OF NMDA RECEPTOR ANTAGONISTS : AN OVERVIEW , 1994 .
[59] Kenjiro Mori,et al. Halothane and Diazepam Inhibit Ketamine‐induced c‐fos Expression in the Rat Cingulate Cortex , 1996, Anesthesiology.
[60] S. Zukin,et al. Adverse reactions to ketamine Anaesthesia , 1981, Anaesthesia.
[61] B. A. van der Kolk. The psychobiology of posttraumatic stress disorder. , 1997, The Journal of clinical psychiatry.
[62] C. E. Reier. Ketamine--"dissociative agent" or hallucinogen? , 1971, The New England journal of medicine.
[63] E. Domino,et al. Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man , 1965, Clinical pharmacology and therapeutics.
[64] N. Maekawa,et al. The Inhibitory Effects of Thiopental, Midazolam, and Ketamine on Human Neutrophil Functions , 1998, Anesthesia and analgesia.
[65] R. Strassman. ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE , 1984, The Journal of nervous and mental disease.
[66] K. Sato,et al. Ketamine stereoselectively inhibits rat dopamine transporter , 1999, Neuroscience Letters.
[67] D. Cyril D’Souza,et al. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans , 1998, Psychopharmacology.
[68] A. Ganong,et al. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. , 1988, Annual review of neuroscience.
[69] K. Williams,et al. Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. , 1992, Molecular pharmacology.
[70] J. Olney,et al. Excitotoxity and the NMDA receptor , 1987, Trends in Neurosciences.
[71] I. Feinberg,et al. Observations on delta homeostasis, the one-stimulus model of NREM-REM alternation and the neurobiologic implications of experimental dream studies , 1995, Behavioural Brain Research.
[72] T. Schorn,et al. Are there long-term effects of ketamine on the central nervous system? , 1980, British journal of anaesthesia.
[73] H. Benveniste,et al. Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis , 1984, Journal of neurochemistry.
[74] P Grimes,et al. Acute reversible cataract induced by xylazine and by ketamine-xylazine anesthesia in rats and mice. , 1986, Experimental eye research.
[75] P. A. Taylor,et al. Depression of Laryngeal Reflexes during Ketamine Anaesthesia , 1971, British medical journal.
[76] A. Maurset,et al. Interaction of the chiral forms of ketamine with opioid, phencyclidine, σ and muscarinic receptors , 1995 .
[77] J. White,et al. Pharmacological properties of ketamine. , 1996, Drug and alcohol review.
[78] T. Kudo,et al. Effects of Ketamine on Adrenocortical Function in Man , 1970, Anesthesia and analgesia.
[79] T. Hilden,et al. The psychotropic effect of ketamine. , 1988, Journal of psychoactive drugs.
[80] Takao Shimizu,et al. Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice , 1991, Pharmacology Biochemistry and Behavior.
[81] A. Perel,et al. Recurrent hallucinations following ketamine , 1976, Anaesthesia.
[82] K. Jansen. Near death experience and the NMDA receptor. , 1989, BMJ.
[83] A. Weil,et al. Chocolate to Morphine: Understanding Mind-Active Drugs , 1983 .
[84] Herbert Weingartner,et al. NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.
[85] James V. Hinrichs,et al. Ketamine: behavioral effects of subanesthetic doses. , 1984, Journal of clinical psychopharmacology.
[86] P Hejja,et al. A consideration of ketamine dreams , 1975, Canadian Anaesthetists' Society journal.
[87] L. Hokin,et al. Lithium stimulates glutamate "release" and inositol 1,4,5-trisphosphate accumulation via activation of the N-methyl-D-aspartate receptor in monkey and mouse cerebral cortex slices. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[88] S. Finestone,et al. Sensory Disturbances Following Ketamine Anesthesia: Recurrent Hallucinations , 1973, Anesthesia and analgesia.
[89] G. Ellison. The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias , 1995, Brain Research Reviews.
[90] D. Shewan,et al. Illicit use of ketamine in Scotland. , 1996, Journal of psychoactive drugs.
[91] W. Engelhardt. [Recovery and psychomimetic reactions following S-(+)-ketamine]. , 1997, Der Anaesthesist.
[92] J. Krystal,et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. , 2000, Archives of general psychiatry.
[93] J. Ryan,et al. Ketamine Does Not Trigger Malignant Hyperthermia in Susceptible Swine , 1989, Anesthesia and analgesia.
[94] B. Chraemmer-jørgensen,et al. PSYCHOMIMETIC REACTIONS AFTER LOW-DOSE KETAMINE INFUSION Comparison with neuroleptanaesthesia , 1983 .
[95] R. Faull,et al. Excitatory amino acid receptors in the human cerebral cortex: A quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine,l-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites , 1989, Neuroscience.
[96] R. Petersen,et al. Ketamine: behavioral effects of subanesthetic doses. , 1985, Journal of clinical psychopharmacology.
[97] F. M. Borgbjerg,et al. Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. , 1997, European journal of pharmacology.
[98] A. Matsuki,et al. Arterial hypoxemia caused by intravenous ketamine. , 1976 .
[99] Rex Y. Wang,et al. M100907, A Selective 5-HT2A Receptor Antagonist and a Potential Antipsychotic Drug, Facilitates N-Methyl-D-Aspartate–Receptor Mediated Neurotransmission in the Rat Medial Prefrontal Cortical Neurons In Vitro , 1998, Neuropsychopharmacology.
[100] E. Krupitsky,et al. Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. , 1997, Journal of psychoactive drugs.
[101] F. Vollenweider,et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) , 1997, European Neuropsychopharmacology.
[102] M. Murphy,et al. Ketamine in the ED: medical politics versus patient care. , 1999, The American journal of emergency medicine.
[103] John H Krystal,et al. Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.
[104] ARVIND G. BHAGWAT,et al. Brain Drain , 1971, Nature.
[105] J. Felser,et al. Dystonic reaction after ketamine abuse. , 1982, Annals of emergency medicine.
[106] G. Thompson. Ketamine-induced convulsions. , 1972, Anesthesiology.
[107] B. Moghaddam,et al. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[108] W. Engelhardt. Aufwachverhalten und psychomimetische Reaktionen nach S-(+)-Ketamin , 1997, Der Anaesthesist.
[109] J. Bostwick,et al. Ketamine dependence in anesthesia providers. , 1999, Psychosomatics.
[110] C. McKay,et al. Ketamine abusers presenting to the emergency department: a case series. , 2000, The Journal of emergency medicine.
[111] F. Sharp,et al. Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics. , 1994, Psychopharmacology bulletin.
[112] A. E. Slaby,et al. Handbook of Psychiatric Emergencies , 1986 .
[113] Hurt Ph,et al. A case of ketamine dependence. , 1994 .
[114] S. F. Nielsen,et al. Psychological Changes in Children after Anaesthesia: A Comparison between Halothane and Ketamine , 1977, Acta anaesthesiologica Scandinavica.
[115] A. Artru,et al. Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. , 1996, Journal of neurosurgery.
[116] A. Malhotra,et al. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. , 1999, The American journal of psychiatry.
[117] K. Jansen. The Ketamine Model of the Near-Death Experience: A Central Role for the N-Methyl-D-Aspartate Receptor , 1997 .
[118] H. Kimura,et al. High-dose ketamine does not induce c-Fos protein expression in rat hippocampus , 1993, Neuroscience Letters.
[119] J. Olney. Neurotoxicity of NMDA receptor antagonists: an overview. , 1994, Psychopharmacology bulletin.